HomeNewsNews

IACR Newsflash

New guidelines on staging of paediatric cancers

New Paediatric Non-Stage Prognosticator Guidelines & an update of 2014 Toronto Stage Guidelines by the International Agency for Research on Cancer (IARC) & partners have been published. 

The guidelines were developed by a panel of international experts and stakeholders during a meeting held at IARC, covering the collection of standardized information, which facilitates the interpretation and comparison of data on survival and mortality across regions and over time. The panel also reviewed and updated the 2014 Toronto Paediatric Cancer Stage Guidelines.

Read the article in the Lancet Oncology here:  Development of paediatric non-stage prognosticator guidelines for population-based cancer registries and updates to the 2014 Toronto Paediatric Cancer Stage Guidelines

 

Cancer registry news on Twitter

If you are on Twitter, follow GICR @ IARC for the latest on cancer registration, cancer data and cancer control activities and updates around the world

For our cancer registry members and colleagues: contact us if you would like us to share your publications, research and activities on this website, our mailing list and on twitter.

 

Results Overview of the Cancer Registries and COVID-19 Survey

In mid-May, the COVID-19 and Cancer Task Force, through IACR and GICR, reached out to cancer registries with a survey to assess the impact of the COVID-19 pandemic on cancer registration. A total of 218 cancer registries from 90 countries participated in this survey.  We therefore extend our most sincere thank you to each registry for taking the time to provide feedback on how the COVID-19 pandemic has impacted their respective cancer registry operations

We are pleased to share an overview of the survey results:

Covid19 survey1 Respondents

 

Two out of three cancer registries indicated their operations, including staff performance and funding, were disrupted due to the pandemic.

Covid19 survey1 Reg operations

 

For 71% of registries, staff attendance was affected by the pandemic.

Covid19 survey1 Staff

 

We will provide the detailed results from this survey very soon – please stay tuned!

Again, thank you to all our colleagues for helping us assess the impact of COVID-19 on cancer registration.  The information, comments and suggestions you shared will help all those in the Task Force, IARC, GICR and IACR in particular, gather and provide targeted support for registry activities in the near future.

 

 

 

IARC IACR GICR2020

 

Enrico Anglesio 2020 Virtual Prize

The Enrico Anglesio Prize is awarded every year to a young cancer epidemiology researcher, in two occasions:

  1. It has been part of the regular programme and prize awarded at the IACR's Annual Scientific Conference; and 

  2. At the yearly Groupe pour l’Epidémiologie et l’Enregistrement du cancer dans les Pays de Langue Latine (GRELL) Meeting.

With the cancellaction of conferences for 2020 due to COVD-19, the Fondo Elena Moroni and the scientific committee of the Enrico Anglesio prize decided to organise a virtual edition for 2020.  

For the virutal prize, candidates are invited to present a written paper on their work on cancer epidemiology and/or cancer registration, that, in normal times, they would have been given as an oral presentation at the IACR or GRELL conference, and subsequently submitted for publication in a Journal.  READ more of the prize details and rules here:  https://www.fondoelenamoroni.org/en/the-prize/

Click here to download the rules and application form (word):  

https://www.fondoelenamoroni.org/wp-content/uploads/2020/07/Rules_and_forms.doc

A jury will select five finalists to continue to the next phase which will involve preparation of an 8 minute video presentation of their work.  The winner will receive a 500 Euro prize, and if the winning work is published within one year in a scientific journal with impact factor, the prize amount will be multiplied upon publication. The basic amount of the Prize is doubled to 1000 Euro if the work is published on a Journal with impact factor over 4.00; it is multiplied by three (reaching 1500 Euro) if the work is published on a journal with impact factor over 8.00.

The deadline for submission of the manuscript is September 15, 2020. The candidate must be first or only author on the submitted paper, that has not been previously published.

 

COVID-19 and Cancer Registries Survey

IARC IACR GICR2020

 

IARC, GICR and IACR is currently inviting cancer registries to respond to an online survey to assess the impact of the COVID-19 pandemic on cancer registration. The survey is being sent by email to registries and is likewise available here: https://is.gd/IACR_GICR_Survey1

PDF copies of survey translations in French, Spanish and Portugese are available for download here:

Encuesta de registros de cáncer IARC-IACR-GICR - español 

Enquête IARC-IACR-GICR sur les registres du cancer - français

​Pesquisa sobre registros de câncer da IARC-IACR-GICR- Português

The survey is in support of the COVID-19 and Cancer Task Force to help coordinate efforts to synthesize and rapidly disseminate data on how the coronavirus disease (COVID-19) pandemic is affecting cancer outcomes worldwide.   

The deadline for completing the survey has been extended to 22nd May 2020.

  •  Start 
  •  Prev 
  •  1  2  3 
  •  Next 
  •  End 

Page 1 of 3

Our partners

120507 01b LOGO X3

 

iarc-logo

 

encr-logo

This website was developed and is hosted at the International Agency for Research on Cancer (IARC)
Go to top